Entyvio Pen — Point32Health

Initial criteria

• Documented diagnosis of Crohn’s disease
• Patient age ≥ 18 years
• Prescribed by or in consultation with a gastroenterologist
• Documentation of one (1) of the following: (a) Trial and failure of at least two of the listed medications from each of the following therapeutic categories (only one medication is required if only one is available for a listed therapeutic category): Interleukin Antagonists (Omvoh, Skyrizi, Tremfya, Yesintek), Janus Kinase Inhibitors (Rinvoq), Tumor Necrosis Factors (Cimzia, Humira) OR (b) Contraindication to all of the following medications: Omvoh, Skyrizi, Tremfya, Yesintek, Rinvoq, Cimzia, and Humira